Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer
The program, funded by Singapore's National Research Foundation, aims to identify Epstein-Barr virus strains associated with NPC in Southeast Asian populations.
Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests
The new funding brings the total investment in the firm to $51 million, which Naveris will use for commercialization of its NavDx assay.
Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study
The study will analyze blood samples of up to 96 patients using Illumina's TruSight Oncology 500 circulating tumor DNA comprehensive genomic profiling assay.
The company plans to publish new data on clinical sensitivity and specificity and has initiated multiple studies investigating new use cases.
Yourgene Health to Distribute Take2 Health Nasopharyngeal Cancer Screening Test in Taiwan
Yourgene's Taipei subsidiary will promote the Take2 Prophecy test in Taiwan and will establish a clinical network for the collection of patient blood samples.